Citadel Advisors - ALTERITY THERAPEUTICS LTD ownership

ALTERITY THERAPEUTICS LTD's ticker is ATHE and the CUSIP is 02155X106. A total of 12 filers reported holding ALTERITY THERAPEUTICS LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ALTERITY THERAPEUTICS LTD
ValueSharesWeighting
Q1 2022$19,000
+26.7%
23,576
+100.5%
0.00%
Q3 2021$15,000
-69.4%
11,761
-69.0%
0.00%
Q2 2021$49,000
-47.9%
37,980
-41.6%
0.00%
Q1 2021$94,00065,0110.00%
Other shareholders
ALTERITY THERAPEUTICS LTD shareholders Q4 2021
NameSharesValueWeighting ↓
OLD MISSION CAPITAL LLC 12,707$17,0000.00%
ADVANTAGE INVESTMENT MANAGEMENT, LLC 1,065$1,0000.00%
UBS Group AG 6,339$8,0000.00%
NEXT Financial Group, Inc 583$1,0000.00%
Advisor Group, Inc. 2,500$3,0000.00%
WELLS FARGO & COMPANY/MN 500$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 12,128$16,0000.00%
MORGAN STANLEY 228,200$299,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11,451$15,0000.00%
View complete list of ALTERITY THERAPEUTICS LTD shareholders